Patents Assigned to Glrotherapy Limited
  • Cancer therapy
    Patent number: 9603912
    Abstract: An agent that stimulates antiviral immunity may be used, for the treatment of cancer. A product comprising an immunostimulant and a vector comprising a transgene that promotes death of neoplastic cells, may also be used for simultaneous, sequential or separate administration in the treatment of cancer.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: March 28, 2017
    Assignee: Glrotherapy Limited
    Inventors: Timothy Farries, David Eckland